Stockreport

Athenex's KX2-391 completes patient enrollment for both Phase III clinical studies months ahead of schedule [Seeking Alpha]

Athenex, Inc.  (ATNX) 
Last athenex, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.athenex.com
PDF Athenex's KX2-391 completes patient enrollment for both Phase III clinical studies months ahead of scheduleAthenex (ATNX-0.5%)reports Q1 revenue growth of 726% Y/Y to $3 [Read more]